Advertisement
Singapore markets open in 5 hours 40 minutes

  • Straits Times Index

    3,313.35
    +9.69 (+0.29%)
     

  • S&P 500

    5,246.48
    +25.06 (+0.48%)
     

  • Dow

    39,587.02
    +155.51 (+0.39%)
     

  • Nasdaq

    16,516.33
    +128.09 (+0.78%)
     

  • Bitcoin USD

    61,476.94
    -1,538.27 (-2.44%)
     

  • CMC Crypto 200

    1,264.91
    -26.49 (-2.05%)
     

  • FTSE 100

    8,428.13
    +13.14 (+0.16%)
     

  • Gold

    2,362.30
    +19.30 (+0.82%)
     

  • Crude Oil

    78.07
    -1.05 (-1.33%)
     

  • 10-Yr Bond

    4.4450
    -0.0360 (-0.80%)
     

  • Nikkei

    38,356.06
    +176.60 (+0.46%)
     

  • Hang Seng

    19,073.71
    -41.35 (-0.22%)
     

  • FTSE Bursa Malaysia

    1,605.88
    +2.97 (+0.19%)
     

  • Jakarta Composite Index

    7,083.76
    -15.50 (-0.22%)
     

  • PSE Index

    6,608.36
    +4.11 (+0.06%)
     

Sanofi to publish COVID-19 vaccine price in development with GSK after Phase I/II trial results

Reuters
FILE PHOTO: A Sanofi logo is seen during the company's annual results news conference in Paris, France

PARIS (Reuters) - French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.

The company is expected to release the results from the Phase I/II clinical trials this month.

It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.

(Reporting by Matthias Blamont in Paris; Writing by Josephine Mason in London; Editing by Jon Boyle)